134 related articles for article (PubMed ID: 38558411)
1. Reverse-engineered exclusive enteral nutrition in pediatric Crohn's disease: A pilot trial.
Lee D; Braly K; Nuding M; Braly I; Hopp C; Twible H; Pope C; Hayden HS; Hoffman L; Zheng H; Wahbeh G; Suskind DL
J Pediatr Gastroenterol Nutr; 2024 May; 78(5):1135-1142. PubMed ID: 38558411
[TBL] [Abstract][Full Text] [Related]
2. Bacterial Taxa and Functions Are Predictive of Sustained Remission Following Exclusive Enteral Nutrition in Pediatric Crohn's Disease.
Jones CMA; Connors J; Dunn KA; Bielawski JP; Comeau AM; Langille MGI; Van Limbergen J
Inflamm Bowel Dis; 2020 Jun; 26(7):1026-1037. PubMed ID: 31961432
[TBL] [Abstract][Full Text] [Related]
3. Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.
Levine A; Wine E; Assa A; Sigall Boneh R; Shaoul R; Kori M; Cohen S; Peleg S; Shamaly H; On A; Millman P; Abramas L; Ziv-Baran T; Grant S; Abitbol G; Dunn KA; Bielawski JP; Van Limbergen J
Gastroenterology; 2019 Aug; 157(2):440-450.e8. PubMed ID: 31170412
[TBL] [Abstract][Full Text] [Related]
4. Partial enteral nutrition induces clinical and endoscopic remission in active pediatric Crohn's disease: results of a prospective cohort study.
Urlep D; Benedik E; Brecelj J; Orel R
Eur J Pediatr; 2020 Mar; 179(3):431-438. PubMed ID: 31781933
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition.
Svolos V; Hansen R; Nichols B; Quince C; Ijaz UZ; Papadopoulou RT; Edwards CA; Watson D; Alghamdi A; Brejnrod A; Ansalone C; Duncan H; Gervais L; Tayler R; Salmond J; Bolognini D; Klopfleisch R; Gaya DR; Milling S; Russell RK; Gerasimidis K
Gastroenterology; 2019 Apr; 156(5):1354-1367.e6. PubMed ID: 30550821
[TBL] [Abstract][Full Text] [Related]
6. The impact of exclusive enteral nutrition on the gut microbiome and bile acid metabolism in pediatric Crohn's disease.
Lv Y; Lou Y; Liu A; Cheng Q; Yang G; Xu C; Luo Y; Lou J; Yu J; Fang Y; Zhao H; Peng K; Ni Y; Chen J
Clin Nutr; 2023 Feb; 42(2):116-128. PubMed ID: 36527826
[TBL] [Abstract][Full Text] [Related]
7. Formula modifications to the Crohn's disease exclusion diet do not impact therapy success in paediatric Crohn's disease.
Landorf E; Hammond P; Abu-Assi R; Ellison S; Boyle T; Comerford A; Couper R
J Pediatr Gastroenterol Nutr; 2024 Jun; 78(6):1279-1286. PubMed ID: 38623960
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn's disease.
Zhou S; Huang Z; Hou W; Lin Y; Yu J
Inflamm Res; 2024 Feb; 73(2):199-209. PubMed ID: 38168701
[TBL] [Abstract][Full Text] [Related]
9. Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn disease.
Copova I; Hradsky O; Zarubova K; Gonsorcikova L; Potuznikova K; Lerchova T; Nevoral J; Bronsky J
Eur J Pediatr; 2018 Nov; 177(11):1685-1693. PubMed ID: 30128744
[TBL] [Abstract][Full Text] [Related]
10. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach.
Day AS; Whitten KE; Lemberg DA; Clarkson C; Vitug-Sales M; Jackson R; Bohane TD
J Gastroenterol Hepatol; 2006 Oct; 21(10):1609-14. PubMed ID: 16928225
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Nutritional and Biological Therapy in North American Children with Active Crohn's Disease.
Lee D; Baldassano RN; Otley AR; Albenberg L; Griffiths AM; Compher C; Chen EZ; Li H; Gilroy E; Nessel L; Grant A; Chehoud C; Bushman FD; Wu GD; Lewis JD
Inflamm Bowel Dis; 2015 Aug; 21(8):1786-93. PubMed ID: 25970545
[TBL] [Abstract][Full Text] [Related]
12. The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial.
Yanai H; Levine A; Hirsch A; Boneh RS; Kopylov U; Eran HB; Cohen NA; Ron Y; Goren I; Leibovitzh H; Wardi J; Zittan E; Ziv-Baran T; Abramas L; Fliss-Isakov N; Raykhel B; Gik TP; Dotan I; Maharshak N
Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):49-59. PubMed ID: 34739863
[TBL] [Abstract][Full Text] [Related]
13. Effect of Exclusive Enteral Nutrition on the Disease Process, Nutrition Status, and Gastrointestinal Microbiota for Chinese Children With Crohn's Disease.
Tang W; Huang Y; Shi P; Wang Y; Zhang Y; Xue A; Tang Z; Hu W; Sun H; Zhang P; Zheng C; Shi J; Wang S; Qiu X; Lu X; Miao S; Meng Y
JPEN J Parenter Enteral Nutr; 2021 May; 45(4):826-838. PubMed ID: 32510616
[TBL] [Abstract][Full Text] [Related]
14. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease.
Ong C; Lim PT; Logarajah V; Liwanag MJ; Ang BX; Cher Y; Chiou FK; Kader A
BMC Gastroenterol; 2018 Dec; 18(1):185. PubMed ID: 30541458
[TBL] [Abstract][Full Text] [Related]
15. [Exclusive enteral nutrition continues to be first line therapy for pediatric Crohn's disease in the era of biologics].
Navas-López VM; Blasco-Alonso J; Lacasa Maseri S; Girón Fernández-Crehuet F; Serrano Nieto MJ; Vicioso Recio MI; Sierra Salinas C
An Pediatr (Barc); 2015 Jul; 83(1):47-54. PubMed ID: 24704330
[TBL] [Abstract][Full Text] [Related]
16. Early Mucosal Healing with Exclusive Enteral Nutrition is Associated with Improved Outcomes in Newly Diagnosed Children with Luminal Crohn's disease.
Grover Z; Burgess C; Muir R; Reilly C; Lewindon PJ
J Crohns Colitis; 2016 Oct; 10(10):1159-64. PubMed ID: 26980840
[TBL] [Abstract][Full Text] [Related]
17. Oral exclusive enteral nutrition for induction of clinical remission, mucosal healing, and improvement of nutritional status and growth velocity in children with active Crohn's disease - a prospective multicentre trial.
Matuszczyk M; Meglicka M; Landowski P; Czkwianianc E; Sordyl B; Szymańska E; Kierkuś J
Prz Gastroenterol; 2021; 16(4):346-351. PubMed ID: 34976243
[TBL] [Abstract][Full Text] [Related]
18. Serial fecal calprotectin changes in children with Crohn's disease on treatment with exclusive enteral nutrition: associations with disease activity, treatment response, and prediction of a clinical relapse.
Gerasimidis K; Nikolaou CK; Edwards CA; McGrogan P
J Clin Gastroenterol; 2011 Mar; 45(3):234-9. PubMed ID: 20871409
[TBL] [Abstract][Full Text] [Related]
19. Effect of the Crohn's Disease Exclusion Diet (CDED) on the Fecal Calprotectin Level in Children with Active Crohn's Disease.
Matuszczyk M; Meglicka M; Wiernicka A; Jarzębicka D; Osiecki M; Kotkowicz-Szczur M; Kierkuś J
J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887910
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of induction therapy with exclusive enteral nutrition in pediatric Crohn's disease].
Luo YY; Fang YH; Yu JD; Xu LJ; Sun MF; Cheng Q; Chen J
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jun; 24(6):626-630. PubMed ID: 35762427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
